Professor Michael Loebinger

Sub-specialties: Respiratory Medicine, Bronchiectasis, Non-tuberculous Mycobacteria, Tuberculosis, Respiratory Infections, COVID/Post-COVID syndromes, Breathlessness, General Respiratory Medicine, Asthma, COPD, Lung Health.

Overview

02036532006

Overview

Prof Michael Loebinger is a Consultant Respiratory Physician at Royal Brompton, where he leads the lung division and host defence unit. He has particular expertise in bronchiectasis, primary ciliary dyskinesia, chronic infection, host defence abnormalities, and bacterial, fungal and mycobacterial infections. He is Professor of Practice at Imperial and has published over 150 papers and leads global international studies and guidelines.

About Professor Michael Loebinger

Professor Michael Loebinger is a Consultant Respiratory Physician here at OneWelbeck Lung Health. He also leads the lung division at Royal Brompton and Harefield Hospitals. He specialises in respiratory infection and also leads the host defence unit, which is one of the most respected respiratory infection units in the world, looking after some of the largest global cohorts of patients with bronchiectasis, non tuberculous mycobacteria (NTM) and fungal disease. He has helped shape international clinical practice and co-chaired the British Thoracic Society (BTS) bronchiectasis guidelines and co-wrote the BTS NTM and European respiratory Society (ERS) bronchiectasis guidelines. He is a founding member of the UK and European clinical and research bronchiectasis and NTM networks, and leads global multicentre clinical trials.

He has an active research programme, which has produced over 150 publications, media interest and grant awards and he was awarded Professor of Practice (Respiratory Medicine) at Imperial College in 2018. He is also a very keen footballer having represented Cambridge and Oxford University 1st teams in fixtures which have included English Premier League reserve teams, a passion that he is also living vicariously through his children.

Areas of Expertise

Dr Loebinger treats a range of conditions, including:

Bronchiectasis
Non-tuberculous mycobacteria (NTM)
Tuberculosis (TB)
Respiratory infection
COVID-19
Fungal lung disease
Breathlessness
Cough
Asthma
COPD

Treatments:

General Respiratory Medicine

Additional Information

Clinical Posts:

Professor Michael Loebinger MA FRCP PhD
Director of the Lung Division, Clinical Director of Laboratory Medicine, Deputy Medical Director, Consultant Respiratory Medicine
Royal Brompton & Harefield Hospitals
Royal Brompton Hospital, Sydney Street, London, SW3 6NP
Guys and St Thomas’ NHS Foundation Trust
Professor of Practice (Respiratory Medicine)
National Heart and Lung Institute
Imperial College London

Memberships:

Fellow of the Royal College of Physicians
European Respiratory Society - Chair Infection Group
British Thoracic Society
European Research Network

Awards:

2023 National Clinical Impact Award
2019 National Clinical Excellence Award
2018 Award for innovation in non-tuberculous Mycobacteria, European Respiratory Society (ERS)
2010 Prize and Bursary, Medical Research Society (MRS).
2009 Young Investigator of the Year Winner, Royal Society of Medicine (RSM).
Young Investigator of the Year Winner, British Association of Lung Research.
Best of all American Thoracic Society Scholars.
International Trainee Fellowship, American Thoracic Society.
Young Investigator of the Year Winner, ERS.
2008 Young Investigator of the Year Winner, British Thoracic Society.
2006 Medical Research Council Clinical Research Training Fellowship.

Research Highlights

Include journals such as New England Journal of Medicine, Lancet Respiratory Medicine and Nature Communications:

https://www.imperial.ac.uk/people/m.loebinger/publications.html

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.